A quarterly report with no year-earlier quarter beside it
INUNEKO-SEIKATSU Co., Ltd. (TSE: 556A), a pet-products company whose main product is a dental-care food topping sold as Dental Furikake, published non-consolidated results for the first quarter of the fiscal year ending April 2027 — May 1 to July 31, 2026 — on September 14, 2026 under Japanese GAAP. Revenue was ¥1,287 million, operating profit ¥185 million, ordinary profit ¥184 million and net profit ¥116 million, for earnings of ¥42.99 per share, or ¥40.21 fully diluted. The company did not prepare quarterly financial statements for the first quarter of FY4/2026, so the filing prints no year-earlier figures and no growth rates, and every prior-year cell in the profit rows of the table is a dash. The shares are listed on the Tokyo Stock Exchange.
Advertising is the largest cost: ¥380 million, or 29.5% of revenue
Cost of sales was ¥332.0 million, leaving gross profit of ¥955 million — a gross margin of 74.2%, which is what allows a company of this size to spend heavily on marketing. Selling, general and administrative expenses totalled ¥770 million, and the filing names two items within them: advertising of ¥380.0 million, equal to 29.5% of revenue and 49.3% of SG&A, and salaries and allowances of ¥75.7 million. What remained was operating profit of ¥185.5 million, an operating margin of 14.4%.
Very little happened below the operating line. Non-operating income was ¥0.5 million, of which ¥0.1 million was interest, and non-operating expenses ¥1.5 million, including ¥0.2 million of interest and ¥0.4 million of fees, so ordinary profit and pre-tax profit were identical at ¥184.6 million. Taxes took a larger bite: current taxes of ¥30.8 million and a deferred-tax charge of ¥37.3 million, ¥68.1 million in all, an effective rate of about 36.9%. The deferred charge matches the ¥37.3 million fall in deferred tax assets on the balance sheet, to ¥75.7 million. Net profit was ¥116.5 million. Depreciation for the quarter was ¥1.5 million and goodwill amortisation ¥5.0 million.
New products, a salon and wider sales channels
The filing describes a pet market in which the number of pets kept, after a period of decline, is showing signs of bottoming out, and in which demand for premium food and healthcare remains firm as pets are increasingly treated as members of the family. It singles out dental-care products, where it expects demand to expand further as owners pay more attention to oral care and product line-ups broaden. On the wider economy it notes a gradual recovery, but weak consumer spending as rising prices push households to save, and persistently high raw-material and logistics costs.
Against that background the company says it expanded sales led by its own e-commerce site, launched a premium version of its main product, Dental Furikake, opened a trimming salon, HANARE Shibuya, and widened the sales channels for products developed jointly with Saishunkan Seiyakusho. Inuneko-Seikatsu reports a single segment, the pet-related business, so the filing gives no breakdown of how much each of these contributed to the quarter's revenue.
A share issue lifted net assets by more than a fifth
Total assets rose 12.0% to ¥2,670 million from ¥2,385 million at April 30, 2026. Current assets rose ¥325.3 million to ¥2,444.2 million, which the filing attributes mainly to cash raised through a third-party allotment of new shares; cash and deposits stood at ¥1,721.7 million against ¥1,527.1 million. Accounts receivable rose to ¥335.6 million from ¥245.1 million, and merchandise and finished goods to ¥283.4 million from ¥254.3 million. Fixed assets fell ¥40.2 million to ¥226.0 million, chiefly because of the ¥37.3 million decline in deferred tax assets.
Liabilities fell. Current liabilities declined ¥83.0 million to ¥476.0 million as income taxes payable dropped ¥68.0 million and consumption taxes payable ¥26.1 million, partly offset by an ¥11.3 million rise in accounts payable, and long-term borrowings fell ¥6.7 million to ¥35.6 million. Net assets rose 21.1% to ¥2,152 million: the third-party allotment and the exercise of stock options added ¥129.1 million each to capital and to the capital reserve, and the quarter's net profit went to retained earnings. The equity ratio rose from 74.5% to 80.6%. Shares issued increased by 103,500 to 2,739,500, and the company holds no treasury stock.
Guidance unchanged, with net profit guided lower
Inuneko-Seikatsu left unchanged the full-year FY4/2027 guidance it published on June 15, 2026: revenue of ¥5,684 million (+26.5%), operating profit of ¥716 million (+19.3%), ordinary profit of ¥720 million (+20.1%) and net profit of ¥468 million (−5.6%), for earnings of ¥172.10 per share. The first quarter delivered 22.7% of guided revenue, 25.9% of guided operating profit, 25.6% of guided ordinary profit and 24.9% of guided net profit. Net profit is guided lower even though operating profit is guided higher, and this filing does not say why. The company paid no dividend for FY4/2026 and forecasts none for FY4/2027.
After the quarter: a second animal hospital
At a board meeting on September 14, 2026 the company resolved to acquire all the shares of Dobutsu no Mori, an animal-hospital operator, for cash, with the combination scheduled for October 1, 2026. It would be the company's second animal hospital, after Masuda Pet Clinic in Shimane Prefecture, which it has already acquired. The filing gives three reasons: securing a location on the outskirts of the Tokyo metropolitan area, building further know-how in running animal hospitals, and raising awareness of the Inuneko-Seikatsu brand by introducing the company's products after the acquisition. The purchase price is not disclosed, at the seller's request; advisory and related fees come to ¥11.1 million, and the amount of goodwill has not yet been determined.
| Metric | Q1 FY4/2027 | Q1 FY4/2026 | Change |
|---|---|---|---|
| Revenue (¥ million) | 1,287 | — | — |
| Gross profit (¥ million) | 955 | — | — |
| Gross margin | 74.2% | — | — |
| SG&A expenses (¥ million) | 770 | — | — |
| Advertising expenses (¥ million) | 380 | — | — |
| Operating profit (¥ million) | 185 | — | — |
| Operating margin | 14.4% | — | — |
| Ordinary profit (¥ million) | 184 | — | — |
| Net profit (¥ million) | 116 | — | — |
| EPS (¥) | 42.99 | — | — |
| Cash and deposits (¥ million) | 1,721 | 1,527 | +12.7% |
| Total assets (¥ million) | 2,670 | 2,385 | +12.0% |
| Net assets (¥ million) | 2,152 | 1,777 | +21.1% |
| Equity ratio | 80.6% | 74.5% | +6.1 pt |
| FY4/2027 guidance — revenue (¥ million) | 5,684 | — | +26.5% |
| FY4/2027 guidance — operating profit (¥ million) | 716 | — | +19.3% |
| FY4/2027 guidance — ordinary profit (¥ million) | 720 | — | +20.1% |
| FY4/2027 guidance — net profit (¥ million) | 468 | — | −5.6% |
| FY4/2027 guidance — EPS (¥) | 172.10 | — | — |
| Annual dividend per share (¥) | 0.00 | 0.00 | unchanged |
JapanStockPulse provides informational content only and does not constitute investment advice. Figures are taken from the company's published earnings short report and may be subject to subsequent revision.